Joint RFP Announced: Therapeutic Innovation Award

The Mark Foundation has partnered with the Chordoma Foundation as sponsor of the Therapeutic Innovation Award aimed at accelerating the development of drug therapies targeting brachyury, a transcription factor that plays a key role in chordoma and other cancers. Letters of Intent are due Friday, April 6th. Follow this link for details.